{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:07:03Z","timestamp":1791050823633,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,8,1]]},"DOI":"10.1038\/sj.bmt.1703625","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T18:27:46Z","timestamp":1031077666000},"page":"229-234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Allogeneic bone marrow transplantation in patients with follicular lymphoma: a single center study"],"prefix":"10.1038","volume":"30","author":[{"given":"I","family":"Yakoub-Agha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Folliot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Guillerm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Quesnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Bauters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JP","family":"Jouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Morschhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,8,22]]},"reference":[{"key":"BF1703625_CR1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood.V83.4.881.881","volume":"83","author":"SJ Horning","year":"1994","unstructured":"Horning SJ . Treatment approaches to the low-grade lymphomas Blood 1994 83: 881 884","journal-title":"Blood"},{"key":"BF1703625_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1200\/JCO.1991.9.5.762","volume":"9","author":"JE Romaguera","year":"1991","unstructured":"Romaguera JE, McLaughlin P, North L et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model J Clin Oncol 1991 9: 762 769","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR3","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1200\/JCO.1997.15.3.1110","volume":"15","author":"P Brice","year":"1997","unstructured":"Brice P, Bastion Y, Lepage E et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alpha: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 1997 15: 1110 1117","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR4","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1200\/JCO.1998.16.7.2332","volume":"16","author":"P Solal-Celigny","year":"1998","unstructured":"Solal-Celigny P, Lepage E, Brousse N et al. Doxorubicin-containing regimen with or without interferon alpha-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial J Clin Oncol 1998 16: 2332 2338","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1200\/JCO.1996.14.2.514","volume":"14","author":"P Solal-Celigny","year":"1996","unstructured":"Solal-Celigny P, Brice P, Brousse N et al. Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte J Clin Oncol 1996 14: 514 519","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1023\/A:1008376728894","volume":"10","author":"M Lazzarino","year":"1999","unstructured":"Lazzarino M, Orlandi E, Montillo M et al. Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma Ann Oncol 1999 10: 59 64","journal-title":"Ann Oncol"},{"key":"BF1703625_CR7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1200\/JCO.1996.14.4.1262","volume":"14","author":"P McLaughlin","year":"1996","unstructured":"McLaughlin P, Hagemeister F, Romaguera J et al. Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma J Clin Oncol 1996 14: 1262 1268","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR8","first-page":"136","volume":"20","author":"JO Armitage","year":"1993","unstructured":"Armitage JO . Bone marrow transplantation for indolent lymphomas Semin Oncol 1993 20: 136 142","journal-title":"Semin Oncol"},{"key":"BF1703625_CR9","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1182\/blood.V77.11.2524.2524","volume":"77","author":"AS Freedman","year":"1991","unstructured":"Freedman AS, Ritz J, Neuberg D et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma Blood 1991 77: 2524 2529","journal-title":"Blood"},{"key":"BF1703625_CR10","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","volume":"90","author":"D Maloney","year":"1997","unstructured":"Maloney D, Grillo-Lopez A, White C et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma Blood 1997 90: 2188 2195","journal-title":"Blood"},{"key":"BF1703625_CR11","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin P, Grillo-Lopez A, Link B et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program J Clin Oncol 1998 16: 2825 2833","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/108497801300189245","volume":"16","author":"A Aviles","year":"2001","unstructured":"Aviles A, Talavera A, Diaz-Maqueo J et al. Evaluation on a six-dose treatment of anti-CD20 monoclonal antibody in patients with refractory follicular lymphoma Cancer Biother Radiopharm 2001 16: 159 162","journal-title":"Cancer Biother Radiopharm"},{"key":"BF1703625_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1182\/blood.V97.1.101","volume":"97","author":"P Colombat","year":"2001","unstructured":"Colombat P, Salles G, Brousse N et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation Blood 2001 97: 101 106","journal-title":"Blood"},{"key":"BF1703625_CR14","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/sj.bmt.1700781","volume":"19","author":"K Van Besien","year":"1997","unstructured":"Van Besien K, de Lima M, Giralt S et al. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect Bone Marrow Transplant 1997 19: 977 982","journal-title":"Bone Marrow Transplant"},{"key":"BF1703625_CR15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","volume":"84","author":"V Ratanatharathorn","year":"1994","unstructured":"Ratanatharathorn V, Uberti J, Karanes C et al. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma Blood 1994 84: 1050 1055","journal-title":"Blood"},{"key":"BF1703625_CR16","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1200\/JCO.1995.13.5.1096","volume":"13","author":"KW Van Besien","year":"1995","unstructured":"Van Besien KW, Khouri IF, Giralt SA et al. Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management J Clin Oncol 1995 13: 1096 1102","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR17","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1182\/blood.V90.10.4201","volume":"90","author":"L Verdonck","year":"1997","unstructured":"Verdonck L, Dekker A, Lokhorst H et al. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma Blood 1997 90: 4201 4205","journal-title":"Blood"},{"key":"BF1703625_CR18","first-page":"1832","volume":"92","author":"K Van Besien","year":"1998","unstructured":"Van Besien K, Sobocinski K, Rowlings P et al. Allogeneic bone marrow transplantation for low-grade lymphoma Blood 1998 92: 1832 1836","journal-title":"Blood"},{"key":"BF1703625_CR19","first-page":"1120a","volume":"93","author":"M Attal","year":"1997","unstructured":"Attal M, Soci\u00e9 G, Molina L . Allogeneic bone marrow transplantation for refractory and recurrent follicular lymphoma: a case-matched analysis with autologous transplantation from the French bone marrow transplantation group registery data (abstract) Blood 1997 93: 1120a","journal-title":"Blood"},{"key":"BF1703625_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.bmt.1701556","volume":"23","author":"R Stein","year":"1999","unstructured":"Stein R, Greer J, Goodman S et al. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin Bone Marrow Transplant 1999 23: 227 233","journal-title":"Bone Marrow Transplant"},{"key":"BF1703625_CR21","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hemapoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting \u2013 Airlie House, Virginia, November 1997 J Clin Oncol 1999 17: 3835 3849","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR22","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K et al. Report of the Committee on Hodgkin's Disease Staging Classification Cancer Res 1971 31: 1860 1861","journal-title":"Cancer Res"},{"key":"BF1703625_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors Hepatology 1984 4: 116 122","journal-title":"Hepatology"},{"key":"BF1703625_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 1993 118: 255 267","journal-title":"Ann Intern Med"},{"key":"BF1703625_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation 1974 18: 295 304","journal-title":"Transplantation"},{"key":"BF1703625_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P . Non parametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457 481","journal-title":"J Am Stat Assoc"},{"key":"BF1703625_CR27","first-page":"185","volume":"135","author":"R Peto","year":"1972","unstructured":"Peto R, Peto J . Asymptotically efficient rank invariant test procedures J R Stat Soc 1972 135: 185 206","journal-title":"J R Stat Soc"},{"key":"BF1703625_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","volume":"18","author":"I Yakoub-Agha","year":"2000","unstructured":"Yakoub-Agha I, de La Salmoniere P, Ribaud P et al. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients \u2013 report of the French society of bone marrow transplantation J Clin Oncol 2000 18: 963 971","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.bmt.1700904","volume":"20","author":"E Dann","year":"1997","unstructured":"Dann E, Daugherty C, Larson R . Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma Bone Marrow Transplant 1997 20: 369 374","journal-title":"Bone Marrow Transplant"},{"key":"BF1703625_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/sj.bmt.1701587","volume":"23","author":"M Bernard","year":"1999","unstructured":"Bernard M, Dauriac C, Drenou B, Leberre C, Branger B et al. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma Bone Marrow Transplant 1999 23: 329 333","journal-title":"Bone Marrow Transplant"},{"key":"BF1703625_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1200\/JCO.1992.10.6.942","volume":"10","author":"D Weisdorf","year":"1992","unstructured":"Weisdorf D, Andersen J, Glick J, Oken M . Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation J Clin Oncol 1992 10: 942 947","journal-title":"J Clin Oncol"},{"key":"BF1703625_CR32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756 763","journal-title":"Blood"},{"key":"BF1703625_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00001622-199903000-00003","volume":"11","author":"R Champlin","year":"1999","unstructured":"Champlin R, Khouri I, Kornblau S et al. Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus- malignancy Curr Opin Oncol 1999 11: 87 95","journal-title":"Curr Opin Oncol"},{"key":"BF1703625_CR34","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.bmt.1702864","volume":"27","author":"R Champlin","year":"2001","unstructured":"Champlin R, Khouri I, Anderlini P et al. Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation Bone Marrow Transplant 2001 27: (Suppl. 2) S13 22","journal-title":"Bone Marrow Transplant"},{"key":"BF1703625_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1054\/mehy.1997.0659","volume":"52","author":"P Sastry","year":"1999","unstructured":"Sastry P . Adoptive immunotherapy for cutaneous T-cell lymphomas Med Hypotheses 1999 52: 353 354","journal-title":"Med Hypotheses"},{"key":"BF1703625_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev.med.50.1.369","volume":"50","author":"D Porter","year":"1999","unstructured":"Porter D, Antin J . The graft-versus-leukemia effects of allogeneic cell therapy Annu Rev Med 1999 50: 369 386","journal-title":"Annu Rev Med"},{"key":"BF1703625_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/sj.bmt.1702477","volume":"26","author":"G Hale","year":"2000","unstructured":"Hale G, Jacobs P, Wood L et al. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells Bone Marrow Transplant 2000 26: 69 76","journal-title":"Bone Marrow Transplant"},{"key":"BF1703625_CR38","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","volume":"86","author":"S Mackinnon","year":"1995","unstructured":"Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease Blood 1995 86: 1261 1268","journal-title":"Blood"},{"key":"BF1703625_CR39","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood.V86.11.4337.bloodjournal86114337","volume":"86","author":"S Giralt","year":"1995","unstructured":"Giralt S, Hester J, Huh Y et al. CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Blood 1995 86: 4337 4343","journal-title":"Blood"},{"key":"BF1703625_CR40","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","volume":"276","author":"C Bonini","year":"1997","unstructured":"Bonini C, Ferrari G, Verzeletti S et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 1997 276: 1719 1724","journal-title":"Science"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703625","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703625.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703625.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:32:52Z","timestamp":1648078372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,1]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,8,1]]}},"alternative-id":["BF1703625"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703625","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,1]]},"assertion":[{"value":"19 November 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}